During the 12-month study, a total of 10 patients received an alternative anemia therapy at some point (2 high ferritin FCM, 2 low ferritin FCM, 6 oral iron), and in these patients subsequent hepcidin values were excluded from analysis since this could have affected hepcidin concentrations. This evidence concerns the gene HAMP and anemia (phenotype).